Cyclooxygenase-2-derived lipoxin A4 increases gastric resistance to aspirin-induced damage
about
sameAs
Prostaglandins, NSAIDs, and Gastric Mucosal Protection: Why Doesn't the Stomach Digest Itself?Interaction of a selective cyclooxygenase-2 inhibitor with aspirin and NO-releasing aspirin in the human gastric mucosaFactors influencing the eicosanoids synthesis in vivoAspirin, but not NO-releasing aspirin (NCX-4016), interacts with selective COX-2 inhibitors to aggravate gastric damage and inflammationThe effect of single-dose naproxen on eicosanoid formation in human gastroduodenal mucosaEvidence that 5-lipoxygenase and acetylated cyclooxygenase 2-derived eicosanoids regulate leukocyte-endothelial adherence in response to aspirinSurface phospholipids in gastric injury and protection when a selective cyclooxygenase-2 inhibitor (Coxib) is used in combination with aspirinGastrointestinal-sparing effects of novel NSAIDs in rats with compromised mucosal defenceDichotomy in duration and severity of acute inflammatory responses in humans arising from differentially expressed proresolution pathways.A pro-resolution mediator, prostaglandin D(2), is specifically up-regulated in individuals in long-term remission from ulcerative colitis.The development of COX2 inhibitors.H(2)S-releasing aspirin protects against aspirin-induced gastric injury via reducing oxidative stress.Anti-inflammatory effects of chronic aspirin on brain arachidonic acid metabolites.Muc-2-deficient mice display a sex-specific, COX-2-related impairment of gastric mucosal repair.Lack of effects of acemetacin on signalling pathways for leukocyte adherence may explain its gastrointestinal safety.Polyunsaturated fatty acid metabolism signature in ischemia differs from reperfusion in mouse intestine.A novel rat lipoxin A4 receptor that is conserved in structure and function.Success of prostaglandin E2 in structure-function is a challenge for structure-based therapeutics.Cyclooxygenase 2 mediates post-inflammatory colonic secretory and barrier dysfunctionCyclooxygenase 1 is required for pH control at the mouse gastric surface.Pathogenesis of NSAID-induced gastric damage: importance of cyclooxygenase inhibition and gastric hypermotilityEmerging roles for cyclooxygenase-2 in gastrointestinal mucosal defense.Resolution of inflammation in periodontitisAspirin triggers antiinflammatory 15-epi-lipoxin A4 and inhibits thromboxane in a randomized human trial.NSAID gastropathy and enteropathy: distinct pathogenesis likely necessitates distinct prevention strategiesMechanisms, prevention and clinical implications of nonsteroidal anti-inflammatory drug-enteropathy.Recent developments in chimeric NSAIDs as safer anti-inflammatory agents.Commonality of defensive roles of COX-2 in the lung and gutAcetyl salicylic acid induces damage to intestinal epithelial cells by oxidation-related modifications of ZO-1.Aspirin-triggered lipoxin in patients treated with aspirin and selective vs. nonselective COX-2 inhibitors.Lipoxin A(4) attenuates zymosan-induced arthritis by modulating endothelin-1 and its effectsAnti-LeY antibody enhances therapeutic efficacy of celecoxib against gastric cancer by downregulation of MAPKs/COX-2 signaling pathway: correlation with clinical study.Protective role of hydrogen-rich water on aspirin-induced gastric mucosal damage in ratsAnti-inflammatory and pro-resolving properties of benzo-lipoxin A(4) analogs.Novel anti-inflammatory functions for endothelial and myeloid cyclooxygenase-2 in a new mouse model of Crohn's disease.Downregulation of cyclooxygenase-1 is involved in gastric mucosal apoptosis via death signaling in portal hypertensive rats.Annexin-1 is an endogenous gastroprotective factor against indomethacin-induced damage.Low-Dose Aspirin Therapy Does not Increase the Severity of Acute Radiation Proctitis.Effect of Aspirin and ibuprofen either alone or in combination on gastric mucosa and bleeding time and on serum prostaglandin E2 and thromboxane A2 levels in the anaesthetized rats in vivo.
P2860
Q22306448-8C11B350-F036-4600-8B92-4BBF0D6E091EQ24685768-FDE9EE51-1992-444E-9713-55AD0C088C1EQ28083767-7039CB79-DE8E-4C12-926E-3B35F942430AQ28166417-005B22EA-6870-405B-85BC-64BF5AC88494Q28194351-8B56D0F7-BA41-4DA0-869C-E9D0C4265F49Q28196895-657C6324-96F6-44E1-8863-C4C17B80EBA2Q28219464-E2952391-78AA-4735-AE98-5A2B5814C901Q28482202-DF6C1725-149E-457B-A284-EE5B3E7C3E6EQ33928544-82DB51A9-4A95-47CA-A410-25DF09A9CD21Q33977744-47BC61D9-2A21-4952-90A5-66CCA9558229Q34180681-8006BFF6-B253-4EDB-A782-24D020F9DB6FQ34431045-07905188-4AA4-402A-A07D-770461B55360Q34444465-77A45A46-1770-4DF1-8FA3-87CE1FC9E7B6Q34756209-618C3151-E1A9-4726-A29C-B152B7229252Q34807370-BD4B0741-CB82-46B2-9F77-3B739332873CQ35000900-6F8934ED-102E-4DF9-8259-42C02D95E668Q35045249-CE883234-4538-4D7B-AA9A-A1550A0E1940Q35170135-35663712-8DC3-48C9-92EB-B3870D31837DQ35596168-C27931BB-9989-4DB5-8D23-628F1CFA54CEQ35597053-B5B36175-BBF8-4A59-90B6-6AEDBF147B30Q35958226-41718B6B-0A63-451B-AC53-63EBFA587B32Q36075305-7FD46455-D2C0-42E9-9A9A-0421F91C0554Q36309261-3BFCC121-C168-44B8-A7A2-DBF3D978A7D4Q37585451-58E31769-BFB8-481D-BE72-A99022EBC17EQ37882741-E6054AF3-2CA9-46FD-B274-0203F2FAB914Q38097424-E76A60BC-A700-4963-B9DC-66EDD537E3A5Q38260626-68FE5118-76E1-4C24-AD0F-82CF90CAF2B4Q38622970-4AB5C578-3CC9-45AA-AB35-A29E65F0CDFBQ39292091-513818C0-3EDB-4D72-86DA-10B37879FB23Q39318054-B5FF4964-5CC7-44F7-A3CD-BF46DB0AAED1Q41473918-F1080C35-2AB9-45D4-8501-2D722747D9B5Q41589499-CC8661BD-6A99-403A-B4A2-CAF9E3B0302AQ41958529-CD9251B9-D1D8-421D-8B00-C7BBAC180ACCQ42942697-95907F86-BE5F-47BF-B71E-119533FAB933Q43124597-8B1F8064-94D7-4073-A759-448E0F2168D5Q43294876-7F4B1E94-E2BE-41CF-81B0-9E84D233A034Q45096437-0546A225-70EC-4817-9D6F-F4A7DBC22C41Q47155302-FCF774EF-2808-4B86-80B9-DE8DFA2062E3Q50513986-6DFF08EC-DFCD-4642-B6E1-0DADF5847A19
P2860
Cyclooxygenase-2-derived lipoxin A4 increases gastric resistance to aspirin-induced damage
description
2002 nî lūn-bûn
@nan
2002 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Cyclooxygenase-2-derived lipox ...... ance to aspirin-induced damage
@ast
Cyclooxygenase-2-derived lipox ...... ance to aspirin-induced damage
@en
Cyclooxygenase-2-derived lipox ...... ance to aspirin-induced damage
@nl
type
label
Cyclooxygenase-2-derived lipox ...... ance to aspirin-induced damage
@ast
Cyclooxygenase-2-derived lipox ...... ance to aspirin-induced damage
@en
Cyclooxygenase-2-derived lipox ...... ance to aspirin-induced damage
@nl
prefLabel
Cyclooxygenase-2-derived lipox ...... ance to aspirin-induced damage
@ast
Cyclooxygenase-2-derived lipox ...... ance to aspirin-induced damage
@en
Cyclooxygenase-2-derived lipox ...... ance to aspirin-induced damage
@nl
P2093
P356
P1433
P1476
Cyclooxygenase-2-derived lipox ...... ance to aspirin-induced damage
@en
P2093
Andrea Mencarelli
Antonio Morelli
Barbara Palazzetti
Eleonora Distrutti
John L Wallace
Mario Romano
Michael Dicay
Octavio Menezes de Lima
Webb McKnight
P304
P356
10.1053/GAST.2002.36558
P407
P577
2002-11-01T00:00:00Z